-
Cooking with liquefied petroleum gas or biomass and fetal growth outcomes: a multi-country randomised controlled trial Lancet Global Health (IF 34.3) Pub Date : 2024-04-11 William Checkley MD, Lisa M Thompson PhD, Shakir Hossen MBBS, Laura Nicolaou PhD, Kendra N Williams PhD, Stella M Hartinger PhD, Marilu Chiang MD, Kalpana Balakrishnan PhD, Sarada S Garg DNB, Gurusamy Thangavel MSc, Vigneswari Aravindalochanan PhD, Ghislaine Rosa PhD, Alexie Mukeshimana Adv Dip, Florien Ndagijimana MPH, John P McCracken ScD, Anaité Diaz-Artiga MPH, Sheela S Sinharoy PhD, Lance Waller
Household air pollution might lead to fetal growth restriction during pregnancy. We aimed to investigate whether a liquefied petroleum gas (LPG) intervention to reduce personal exposures to household air pollution during pregnancy would alter fetal growth. The Household Air Pollution Intervention Network (HAPIN) trial was an open-label randomised controlled trial conducted in ten resource-limited settings
-
Tuberculosis screening in adults with HIV: beyond symptoms Lancet Global Health (IF 34.3) Pub Date : 2024-04-04 Bianca Sossen, Gary Maartens
-
Thinking beyond diagnostic accuracy to evaluate tuberculosis screening tests Lancet Global Health (IF 34.3) Pub Date : 2024-04-04 Emily L-H MacLean, H Manisha Yapa
-
Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study Lancet Global Health (IF 34.3) Pub Date : 2024-04-04 Byron W P Reeve PhD, Gcobisa Ndlangalavu PhD, Hridesh Mishra PhD, Zaida Palmer MSc, Happy Tshivhula PhD, Loren Rockman BSc (Hons), Selisha Naidoo MSc, Desiree L Mbu MSc, Charissa C Naidoo PhD, Brigitta Derendinger PhD, Prof Gerhard Walzl MD PhD, Stephanus T Malherbe MD PhD, Prof Paul D van Helden PhD, Fred C Semitala MD, Christina Yoon MD, Rishi K Gupta MRCP PhD, Prof Mahdad Noursadeghi FRCP PhD, Prof
Tuberculosis, a major cause of death in people living with HIV, remains challenging to diagnose. Diagnostic accuracy data are scarce for promising triage and confirmatory tests such as C-reactive protein (CRP), sputum and urine Xpert MTB/RIF Ultra (Xpert Ultra), and urine Determine TB LAM Ag (a lateral flow lipoarabinomannan [LF-LAM] test), without symptom selection. We evaluated novel triage and confirmatory
-
Blood RNA biomarkers for tuberculosis screening in people living with HIV before antiretroviral therapy initiation: a diagnostic accuracy study Lancet Global Health (IF 34.3) Pub Date : 2024-04-04 Tiffeney Mann MSc, Rishi K Gupta PhD, Byron W P Reeve PhD, Gcobisa Ndlangalavu PhD, Aneesh Chandran PhD, Amirtha P Krishna BSc, Claire J Calderwood MRCP, Happy Tshivhula PhD, Zaida Palmer MSc, Selisha Naidoo MSc, Desiree L Mbu MSc, Grant Theron PhD, Prof Mahdad Noursadeghi PhD
Undiagnosed tuberculosis remains a major threat for people living with HIV. Multiple blood transcriptomic biomarkers have shown promise for tuberculosis diagnosis. We sought to evaluate their diagnostic accuracy and clinical utility for systematic pre-antiretroviral therapy (ART) tuberculosis screening. We enrolled consecutive adults (age ≥18 years) referred to start ART at a community health centre
-
A Global Tuberculosis Dictionary: unified terms and definitions for the field of tuberculosis Lancet Global Health (IF 34.3) Pub Date : 2024-03-22 Alberto L Garcia-Basteiro, Joanna Ehrlich, Maryline Bonnet, Marianne Calnan, Stephen M Graham, Sabine Hermans, Adriana Jarrett, Rhoda Lewa, Anna Mandalakas, Leonardo Martinez, Giovanni Battista Migliori, Catherine W M Ong, Larissa Otero, Molebogeng Xheedha Rangaka, Mario C B Raviglione, Barbara Seaworth, Willy Ssengooba, Grant Theron, Anete Trajman, Marcel A Behr
-
Bubble continuous positive airway pressure for children with pneumonia and hypoxaemia in Ethiopia Lancet Global Health (IF 34.3) Pub Date : 2024-03-21 Eric D McCollum, Tisungane Mvalo
-
Effectiveness of bubble continuous positive airway pressure for treatment of children aged 1–59 months with severe pneumonia and hypoxaemia in Ethiopia: a pragmatic cluster-randomised controlled trial Lancet Global Health (IF 34.3) Pub Date : 2024-03-21 Meseret Gebre MD, Kassa Haile MPH, Prof Trevor Duke FRACP, Md Tanveer Faruk MPH, Mehnaz Kamal MPH, Md Farhad Kabir MSc, Md Fakhar Uddin MSS, Muluye Shimelis BSc, Tigist Beyene MSc, Bethelhem Solomon MD, Meles Solomon MSc, Abebe Genetu Bayih PhD, Alemseged Abdissa PhD, Taye Tolera Balcha PhD, Rahel Argaw MD, Asrat Demtse MD, Abate Yeshidinber Weldetsadik MD, Abayneh Girma MD, Bitseat W Haile MD, Abu
The safety and efficacy of bubble continuous positive airway pressure (bCPAP) for treatment of childhood severe pneumonia outside tertiary care hospitals is uncertain. We did a cluster-randomised effectiveness trial of locally made bCPAP compared with WHO-recommended low-flow oxygen therapy in children with severe pneumonia and hypoxaemia in general hospitals in Ethiopia. This open, cluster-randomised
-
The health and care workforce in the Pandemic Agreement: championing equity and protecting collective capacity for future pandemics Lancet Global Health (IF 34.3) Pub Date : 2024-03-14 Veena Sriram, Leah Shipton, Julia Smith, Katrina Plamondon
-
Global brain health—the time to act is now Lancet Global Health (IF 34.3) Pub Date : 2024-03-14 Andrea S Winkler, Saksham Gupta, Vikram Patel, Arnold Bhebhe, Agnès Fleury, Camilla G Aukrust, Tarun Dua, Tamara M Welte, Sarbani Chakraborty, Kee B Park
-
No health without brain health Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 The Lancet Global Health
-
Aminoglycosides, deafness, and non-tuberculous mycobacteria Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Francis Drobniewski, Marcia Ashmi, Changchunzi He, Jamie Cheong, Anand Shah
-
Progress towards cultural safety in Indigenous cardiovascular health care and research Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Luke Burchill, Angela Dos Santos
-
High burden of typhoid disease in sub-Saharan Africa calls for urgent roll-out of typhoid conjugate vaccines Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Samuel Kariuki, Robert S Onsare
-
Outcomes of heart failure: gaps in knowledge and needs for action Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Yi Wu, Xi Li
-
Gout is a neglected non-communicable disease in the Pacific Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Cyrille Goarant, Shrish Acharya
-
Typhoid conjugate vaccines: a step towards typhoid control Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Mila Shakya, Andrew J Pollard
-
Excess vaccine-preventable disease mortality due to COVID-19 Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Kimberly M Thompson
-
Is intimate partner violence declining? It's still an open question – Authors' reply Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Ning Ma, Yi Song, Zhihui Li
-
Strengthening health policy modelling in Africa Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 S M Thumbi, Jacquie Oliwa, Sheetal P Silal
-
The gout epidemic in French Polynesia: a modelling study of data from the Ma’i u’u epidemiological survey Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Prof Tristan Pascart MD, Kaja A Wasik PhD, Prof Cristian Preda PhD, Valérie Chune MD, Jérémie Torterat BSc, Nicolas Prud’homme BSc, Maryline Nassih BSN, Agathe Martin BSN, Julien Le Masson BSN, Vahinetua Rodière BSN, Sylvain Frogier BSN, Georges Canova BSN, Jean-Paul Pescheux BSN, Charles Shan Sei Fan MD, Charlotte Jauffret MD, Patrick Claeys BSN, Sarah LeBaron von Baeyer PhD, Stephane E Castel PhD
Gout is the most common cause of inflammatory arthritis worldwide, particularly in Pacific regions. We aimed to establish the prevalence of gout and hyperuricaemia in French Polynesia, their associations with dietary habits, their comorbidities, the prevalence of the allele, and current management of the disease. The Ma’i u’u survey was epidemiological, prospective, cross-sectional, and gout-focused
-
Incidence of typhoid fever in Burkina Faso, Democratic Republic of the Congo, Ethiopia, Ghana, Madagascar, and Nigeria (the Severe Typhoid in Africa programme): a population-based study Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Florian Marks PhD, Justin Im PhD, Se Eun Park PhD, Gi Deok Pak MSc, Hyon Jin Jeon MPH, Lady Rosny Wandji Nana PharmD, Marie-France Phoba Master, Lisette Mbuyi-Kalonji Master, Ondari D Mogeni MPH, Biruk Yeshitela MSc, Ursula Panzner MPH, Ligia María Cruz Espinoza MD, Tigist Beyene MSc, Michael Owusu-Ansah MPH, Sampson Twumasi-Ankrah PhD, Melese Yeshambaw MSc, Ashenafi Alemu MSc, Oluwafemi J Adewusi
Typhoid Fever remains a major cause of morbidity and mortality in low-income settings. The Severe Typhoid in Africa programme was designed to address regional gaps in typhoid burden data and identify populations eligible for interventions using novel typhoid conjugate vaccines. A hybrid design, hospital-based prospective surveillance with population-based health-care utilisation surveys, was implemented
-
Point-of-care testing and treatment of sexually transmitted and genital infections to improve birth outcomes in high-burden, low-resource settings (WANTAIM): a pragmatic cluster randomised crossover trial in Papua New Guinea Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Michaela A Riddell PhD, Lisa M Vallely PhD, Alice Mengi MMedSci, Steven G Badman PhD, Prof Nicola Low MD, Handan Wand PhD, Prof John W Bolnga PhD, Delly Babona MMed, Prof Glen D L Mola FRCOG, Prof Virginia Wiseman PhD, Angela Kelly-Hanku PhD, Prof Caroline S E Homer PhD, Christopher Morgan PhD, Prof Stanley Luchters PhD, David M Whiley PhD, Prof Leanne J Robinson PhD, Lucy Au MSc, Irene Pukai-Gani
, and bacterial vaginosis have been associated with adverse maternal and perinatal outcomes, but there is conflicting evidence on the benefits of antenatal screening and treatment for these conditions. We aimed to determine the effect of antenatal point-of-care testing and immediate treatment of , , , and bacterial vaginosis on preterm birth, low birthweight, and other adverse maternal and perinatal
-
Does acute malnutrition in young children increase the risk of treatment failure following artemisinin-based combination therapy? A WWARN individual patient data meta-analysis Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 WWARN ACT Malaria and Malnutrition Study Group, Kasia Stepniewska, Richard Allan, Anupkumar R Anvikar, Thomas A Anyorigiya, Elizabeth A Ashley, Quique Bassat, Elisabeth Baudin, Anders Bjorkman, Maryline Bonnet, Caroline Boulton, Teun Bousema, Gwenaelle Carn, Verena I Carrara, Umberto D'Alessandro, Timothy ME Davis, Lise Denoeud-Ndam, Meghna Desai, Abdoulaye A Djimde, Grant Dorsey, Jean-François Etard
-
Impact with equity: EDCTP and equitable research partnerships Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Michael Makanga, Pauline Beattie, Dominika Jajkowicz, Thomas Nyirenda, Marcel Tanner, Catherine Hankins
-
Efficacy of typhoid vaccines against culture-confirmed Salmonella Typhi in typhoid endemic countries: a systematic review and meta-analysis Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Rabab Batool MS, Zoya Haq Qamar MBBS, Rehana Abdus Salam PhD, Mohammad Tahir Yousafzai PhD, Prof Per Ashorn MD, Prof Farah Naz Qamar FCPS
Typhoid is a serious public health threat in many low-income and middle-income countries. Several vaccines for typhoid have been recommended by WHO for typhoid prevention in endemic countries. This study aimed to review the efficacy of typhoid vaccines against culture-confirmed serovar Typhi. We searched the Cochrane Central Register of Controlled Trials, MEDLINE, and Embase for studies published in
-
Mortality in patients admitted to hospital with heart failure in China: a nationwide Cardiovascular Association Database-Heart Failure Centre Registry cohort study Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Hua Wang MD, Yingying Li MD, Ke Chai MD, Zheng Long MPH, Zhikai Yang MD, Minghui Du MD, Prof Shengfeng Wang PhD, Prof Siyan Zhan PhD, Yujia Liu MD, Yuhao Wan MD, Prof Fang Wang MD, Prof Peng Yin PhD, Prof Weimin Li MD, Prof Yuhua Liao MD, Prof Yugang Dong MD, Prof Xinli Li MD, Prof Jingmin Zhou MD, Prof Kai-Hang Yiu MD PhD, Prof Maigeng Zhou PhD, Prof Yong Huo MD, Prof Jiefu Yang MD
China has the largest burden of heart failure worldwide. However, large-scale studies on heart failure mortality are scarce. We aimed to investigate mortality and identify risk factors for mortality among patients with heart failure in China. This prospective cohort study used data from the China Cardiovascular Association (CCA) Database-Heart Failure Centre Registry, which were linked to the National
-
Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Anna-Maria Hartner MSc, Xiang Li PhD, Susy Echeverria-Londono PhD, Jeremy Roth PhD, Kaja Abbas PhD, Megan Auzenbergs PhD, Margaret J de Villiers PhD, Prof Matthew J Ferrari PhD, Keith Fraser PhD, Han Fu PhD, Prof Timothy Hallett PhD, Wes Hinsley PhD, Prof Mark Jit PhD, Andromachi Karachaliou PhD, Sean M Moore PhD, Shevanthi Nayagam MD, Timos Papadopoulos PhD, T Alex Perkins PhD, Allison Portnoy PhD
There have been declines in global immunisation coverage due to the COVID-19 pandemic. Recovery has begun but is geographically variable. This disruption has led to under-immunised cohorts and interrupted progress in reducing vaccine-preventable disease burden. There have, so far, been few studies of the effects of coverage disruption on vaccine effects. We aimed to quantify the effects of vaccine-coverage
-
Effects of a culturally informed model of care for Aboriginal and Torres Strait Islander patients with acute coronary syndrome in a tertiary hospital in Australia: a pre-post, quasi-experimental, interventional study Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Danielle L Harrop MBBS, Vivian Bryce MPH, Tanya Kitchener, Sean Grugan MPH, Sonia Renouf, Scott Mitchell BPharm, Gregory Hasking PhD, Debra Pauza GradCert, Gregory Richards BASc, Arnold C T Ng PhD, William Y S Wang PhD
Aboriginal and Torres Strait Islander (Indigenous) peoples with cardiac disease in Australia have worse outcomes than non-Indigenous people with cardiac disease. We hypothesised that the implementation of a culturally informed model of care for Indigenous patients hospitalised with acute coronary syndrome (ACS) would improve their clinical outcomes. For this pre-post, quasi-experimental, interventional
-
Is intimate partner violence declining? It's still an open question Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Kathryn M Yount, Lu Gram, Amber Peterman
-
National plans and awareness campaigns as priorities for achieving global brain health Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Sebastian F Winter MD, Donna Walsh BA, Coriene Catsman-Berrevoets MD, Prof Valery Feigin PhD, Frédéric Destrebecq MA, Prof Suzanne L Dickson PhD, Matilde Leonardi MD, Volker Hoemberg MD, Prof Cristina Tassorelli MD, Maria Teresa Ferretti PhD, Anna Dé MSc, Antonella Santuccione Chadha MD, Chris Lynch BA, Sophia Bakhtadze MD, Deanna Saylor MD, Soonmyung Hwang BS, Kevin Rostasy MD, Prof Benzi M Kluger
Neurological conditions are the leading cause of death and disability combined. This public health crisis has become a global priority with the introduction of WHO's (IGAP). 18 months after this plan was adopted, global neurology stakeholders, including representatives of the OneNeurology Partnership (a consortium uniting global neurology organisations), take stock and advocate for urgent acceleration
-
Onchocerciasis elimination in sub-Saharan Africa requires alternative strategies Lancet Global Health (IF 34.3) Pub Date : 2024-03-11 Alfred K Njamnshi, Wepnyu Y Njamnshi, Joseph N Siewe Fodjo
-
Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis Lancet Global Health (IF 34.3) Pub Date : 2024-03-11 Nyamai Mutono PhD, Prof Maria-Gloria Basáñez PhD, Ananthu James PhD, Wilma A Stolk PhD, Anita Makori BSc, Teresia Njoki Kimani MSc, Prof T Déirdre Hollingsworth PhD, Andreia Vasconcelos PhD, Matthew A Dixon PhD, Prof Sake J de Vlas PhD, Prof S M Thumbi PhD
WHO has proposed elimination of transmission of onchocerciasis (river blindness) by 2030. More than 99% of cases of onchocerciasis are in sub-Saharan Africa. Vector control and mass drug administration of ivermectin have been the main interventions for many years, with varying success. We aimed to identify factors associated with elimination of onchocerciasis transmission in sub-Saharan Africa. For
-
Delivering health for all: the critical role of gender-responsive health systems Lancet Global Health (IF 34.3) Pub Date : 2024-03-07 Angeli Achrekar, Svetlana Akselrod, Helen Clark, Gabriela Cuevas Barron, Michael Charles, Katie Dain, Roopa Dhatt, Maliha Khan, Justin Koonin, Ilayda Orankoy, Swostika Thapaliya, Chantal Umuhoza
-
Diabetes and diabetic retinopathy: the growing public health concerns in India Lancet Global Health (IF 34.3) Pub Date : 2024-02-28 Suraj Singh Senjam
-
National prevalence of vision impairment and blindness and associated risk factors in adults aged 40 years and older with known or undiagnosed diabetes: results from the SMART-India cross-sectional study Lancet Global Health (IF 34.3) Pub Date : 2024-02-28 Sarega Gurudas MSc, Joana C Vasconcelos MSc, Prof A Toby Prevost PhD, Rajiv Raman MS, Ramachandran Rajalakshmi PhD, Kim Ramasamy MS, Viswanathan Mohan PhD, Padmaja K Rani MS, Taraprasad Das MS, Dolores Conroy PhD, Prof Robyn J Tapp PhD, Prof Sobha Sivaprasad FRCOphth, SMART-India Study Collaborators, Pramod Bhende, Janani Surya, Lingam Gopal, Radha Ramakrishnan, Rupak Roy, Supita Das, George Manayath
National estimates of the prevalence of vision impairment and blindness in people with diabetes are required to inform resource allocation. People with diabetes are more susceptible to conditions such as diabetic retinopathy that can impair vision; however, these are often missed in national studies. This study aims to determine the prevalence and risk factors of vision impairment and blindness in
-
The value of longitudinal qualitative approaches in vaccination pilot studies Lancet Global Health (IF 34.3) Pub Date : 2024-02-28 Violet Naanyu
-
Integration of the RTS,S/AS01 malaria vaccine into the Essential Programme on Immunisation in western Kenya: a qualitative longitudinal study from the health system perspective Lancet Global Health (IF 34.3) Pub Date : 2024-02-28 Jenny Hill PhD, Teresa Bange MSc, Jenna Hoyt MSc, Simon Kariuki PhD, Mohamed F Jalloh PhD, Prof Jayne Webster PhD, George Okello PhD
Malaria accounts for over half a million child deaths annually. WHO recommends RTS,S/AS01 to prevent malaria in children living in moderate-to-high malaria transmission regions. We conducted a qualitative longitudinal study to investigate the contextual and dynamic factors shaping vaccine delivery and uptake during a pilot introduction in western Kenya. The study was conducted between Oct 3, 2019,
-
Cost-effectiveness of task-shifting in resource-constrained settings Lancet Global Health (IF 34.3) Pub Date : 2024-02-23 Mary Lou Chatterton, Yared Belete Belay
-
Advancing mental health service delivery in low-resource settings Lancet Global Health (IF 34.3) Pub Date : 2024-02-23 Dong (Roman) Xu, George Chikondi Samu, Jiangyun Chen
-
Implementation strategies to build mental health-care capacity in Malawi: a health-economic evaluation Lancet Global Health (IF 34.3) Pub Date : 2024-02-23 Juan Yanguela MSc, Prof Brian W Pence PhD, Michael Udedi PhD, Jonathan Chiwanda Banda PhD, Kazione Kulisewa MMed, Chifundo C Zimba PhD, Jullita K Malava MA, Christopher Akiba PhD, Josée M Dussault PhD, Abigail M Morrison MPH, Steve Mphonda BA, Prof Mina C Hosseinipour MD, Prof Bradley N Gaynes MD, Prof Stephanie B Wheeler PhD
Depression is a major contributor to morbidity and mortality in sub-Saharan Africa. Due to low system capacity, three in four patients with depression in sub-Saharan Africa go untreated. Despite this, little attention has been paid to the cost-effectiveness of implementation strategies to scale up evidence-based depression treatment in the region. In this study, we investigate the cost-effectiveness
-
Two implementation strategies to support the integration of depression screening and treatment into hypertension and diabetes care in Malawi (SHARP): parallel, cluster-randomised, controlled, implementation trial Lancet Global Health (IF 34.3) Pub Date : 2024-02-23 Prof Brian W Pence PhD, Prof Bradley N Gaynes MD, Michael Udedi PhD, Kazione Kulisewa MMed, Chifundo C Zimba PhD, Christopher F Akiba PhD, Josée M Dussault PhD, Harriet Akello BSc, Jullita K Malava MPH, Amelia Crampin MBChB, Ying Zhang PhD, Prof John S Preisser PhD, Prof Stephanie M DeLong PhD, Prof Mina C Hosseinipour MD
Although evidence-based treatments for depression in low-resource settings are established, implementation strategies to scale up these treatments remain poorly defined. We aimed to compare two implementation strategies in achieving high-quality integration of depression care into chronic medical care and improving mental health outcomes in patients with hypertension and diabetes. We conducted a parallel
-
Ending the neglect of paediatric, maternal, and congenital mpox Lancet Global Health (IF 34.3) Pub Date : 2024-02-21 Nadia Adjoa Sam-Agudu, Dimie Ogoina
-
Paediatric, maternal, and congenital mpox: a systematic review and meta-analysis Lancet Global Health (IF 34.3) Pub Date : 2024-02-21 Nuria Sanchez Clemente PhD, Charlotte Coles MSc, Enny S Paixao PhD, Prof Elizabeth B Brickley PhD, Elizabeth Whittaker PhD, Tobias Alfven PhD, Stephen Rulisa PhD, Nelson Agudelo Higuita MD, Paul Torpiano MD, Priyesh Agravat MBBS, Emma V Thorley MB BChir, Simon B Drysdale PhD, Prof Kirsty Le Doare PhD, Prof Jean-Jacques Muyembe Tamfum PhD
Although mpox has been detected in paediatric populations in central and west Africa for decades, evidence synthesis on paediatric, maternal, and congenital mpox, and the use of vaccines and therapeutics in these groups, is lacking. A systematic review is therefore indicated to set the research agenda. We conducted a systematic review and meta-analysis, searching articles in Embase, Global Health,
-
An indicator framework for the monitoring and evaluation of event-based surveillance systems Lancet Global Health (IF 34.3) Pub Date : 2024-02-13 Adam W Crawley MPH, Kyeng Mercy MPH, Sabrina Shivji MSc, Hannah Lofgren MPH, Daniella Trowbridge MPH, Christine Manthey PhD, Yenew Kebede Tebeje MD, Alexey Wil Clara MD, Kimberly Landry MPH, Stephanie J Salyer DVM
Event-based surveillance (EBS) systems have been implemented globally to support early warning surveillance across human, animal, and environmental health in diverse settings, including at the community level, within health facilities, at border points of entry, and through media monitoring of internet-based sources. EBS systems should be evaluated periodically to ensure that they meet the objectives
-
Correction to Lancet Glob Health 2023; 11: e1978–85 Lancet Global Health (IF 34.3) Pub Date : 2024-02-09
-
Correction to Lancet Glob Health 2023; 11: e1713–24 Lancet Global Health (IF 34.3) Pub Date : 2024-02-09
-
Compounding challenges for Syrian refugees in Türkiye in the wake of the earthquake Lancet Global Health (IF 34.3) Pub Date : 2024-02-07 Rasha Kaloti, Jasmin Lilian Diab, Munzer Alkhalil, Diana Rayes, Aula Abbara
-
Unveiling the crisis of the double burden of malnutrition Lancet Global Health (IF 34.3) Pub Date : 2024-01-29 Biniyam Sahiledengle, Lillian Mwanri
Abstract not available
-
The effect of nutrition-specific and nutrition-sensitive interventions on the double burden of malnutrition in low-income and middle-income countries: a systematic review Lancet Global Health (IF 34.3) Pub Date : 2024-01-29 Nora A Escher, Giovanna C Andrade, Suparna Ghosh-Jerath, Christopher Millett, Paraskevi Seferidi
Background Low-income and middle-income countries (LMICs) experiencing nutrition transition face an increasing double burden of malnutrition (DBM). WHO has urged the identification of risks and opportunities in nutrition interventions to mitigate the DBM, but robust evidence is missing. This review summarises the effect of nutrition-specific and nutrition-sensitive interventions on undernutrition and
-
Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance Lancet Global Health (IF 34.3) Pub Date : 2024-01-23 Marc Mendelson, Ramanan Laxminarayan, Direk Limmathurotsakul, Samuel Kariuki, Martha Gyansa-Lutterodt, Esmita Charani, Sanjeev Singh, Kamini Walia, Ana C Gales, Mirfin Mpundu
To limit the catastrophic effects of the increasing bacterial resistance to antimicrobials on health, food, environmental, and geopolitical security, and ensure that no country or region is left behind, a coordinated global approach is required. In this Viewpoint, we argue that the diverging resource availabilities, needs, and priorities of the Global North and the Global South in terms of the actions
-
Long-term immunity following yellow fever vaccination: a systematic review and meta-analysis Lancet Global Health (IF 34.3) Pub Date : 2024-01-22 Jenny L Schnyder, Hanna K de Jong, Bache E Bache, Frieder Schaumburg, Martin P Grobusch
Background Long-term immunity following yellow fever vaccination remains controversial. We aimed to summarise the literature regarding the long-term protection (≥10 years) conveyed by a single dose of yellow fever vaccination. Methods In this systematic review and meta-analysis, we searched 11 databases from database inception to Aug 24, 2023. We included cohort and cross-sectional studies reporting
-
The life-long protective immunity of yellow fever vaccination: time to review? Lancet Global Health (IF 34.3) Pub Date : 2024-01-22 Aitana Juan-Giner, Joachim Hombach
Abstract not available
-
Correction to Lancet Glob Health 2022; 10: 1715–43 Lancet Global Health (IF 34.3) Pub Date : 2024-01-17
Abstract not available
-
Routine sterile glove and instrument change at the time of abdominal wound closure to prevent surgical site infection (ChEETAh): a model-based cost-effectiveness analysis of a pragmatic, cluster-randomised trial in seven low-income and middle-income countries Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 NIHR Global Health Research Unit on Global Surgery, Mwayi Kachapila, Raymond Oppong, Adesoji O. Ademuyiwa, Aneel Bhangu, Risikat Dauda, Dhruva N. Ghosh, Sivesh K Kamarajah, Ismail Lawani, Antonio Ramos-De la Medina, Mark Monahan, Dion G. Morton, Omar Omar, Maria Picciochi, Stephen Tabiri, Tracy E. Roberts, Peter Brocklehurst, Sohini Chakrabortee, James Glasbey, Pollyanna Hardy, Ewen Harrison, Rachel
Background Surgical site infection (SSI) is a major burden on patients and health systems. This study assessed the cost-effectiveness of routine change of sterile gloves and instruments before abdominal wall closure to prevent SSI. Methods A decision-analytic model was built to estimate average costs and outcomes of changing gloves and instruments before abdominal wall closure compared with current
-
Cost-effectiveness of the expansion of PrEP for HIV infection in the Asia Pacific region Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Benjamin R Bavinton, Nila J Dharan
Abstract not available
-
The urgency of identifying global priorities for hearing loss prevention Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Alessandra Giannella Samelli, Carla Gentile Matas
Abstract not available
-
Latent viral infections as neglected risk factors for long COVID Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Amir Abdoli, Ali Taghipour, Mirza Ali Mofazzal Jahromi, Fatemeh Eftekharian, Reza Sahraei, Mohammad Sadegh Sanie
Abstract not available
-
Priorities for hearing loss prevention and estimates of global cause-specific burdens of hearing loss: a systematic rapid review Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Kavita Prasad BA, Ethan D Borre MD, Lauren K Dillard PhD, Austin Ayer MD, Carolina Der MD PhD, Kathleen E Bainbridge PhD, Prof Catherine M McMahon PhD, Prof Debara L Tucci MD, Prof Blake S Wilson PhD, Prof Gillian D Sanders Schmidler PhD, Prof James Saunders MD
Hearing loss affects approximately 1·6 billion individuals worldwide. Many cases are preventable. We aimed to estimate the annual number of new hearing loss cases that could be attributed to meningitis, otitis media, congenital rubella syndrome, cytomegalovirus, and ototoxic medications, specifically aminoglycosides, platinum-based chemotherapeutics, and antimalarials. We used a targeted and a rapid
-
Noma: neglected no more? Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 The Lancet Global Health
Abstract not available